Related Experiment Video
Updated: May 28, 2026
07:30
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Structural brain changes and cognition in relation to markers of vascular dysfunction.
Julia Miralbell1, Juan José Soriano, Gabriela Spulber
1Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain.
Neurobiology of Aging
|October 22, 2011
Summary
Inflammation and fibrinolysis markers like C-reactive protein and PAI-1 are linked to white matter damage in the brain, potentially impacting cognitive function and cerebrovascular disease.
Area of Science:
- Neuroscience
- Vascular Biology
- Biomarkers
Background:
- Vascular dysfunction is increasingly recognized as a contributor to cognitive decline.
- Understanding the link between blood markers and brain health is crucial for early detection and intervention.
Purpose of the Study:
- To investigate the relationship between blood markers of vascular dysfunction and brain microstructural changes.
- To explore correlations with cognitive performance in individuals without dementia or prior vascular disease.
Main Methods:
- Eighty-six participants aged 50-65 from the Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study were analyzed.
- Blood levels of inflammatory biomarkers (CRP, resistin) and fibrinolysis inhibitors (PAI-1, Lp(a)) were measured.
- Correlations with diffusion tensor imaging (DTI) for white matter integrity, gray matter volume, and cognitive tests were assessed.
Main Results:
- Elevated C-reactive protein and PAI-1 levels correlated with white matter integrity loss in key brain pathways.
- This association was independent of age, sex, and vascular risk factors.
- PAI-1 levels were also linked to reduced processing speed and visuomotor coordination; no biomarkers related to gray matter volume.
Conclusions:
- Inflammation and fibrinolysis dysregulation may play a role in white matter damage in cerebrovascular disease.
- These factors could contribute to cognitive impairment through microstructural brain changes.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...